- ICH GCP
- Registro de ensayos clínicos de EE. UU.
- Ensayo clínico NCT07943299
Patient Experience Across Dental Implant Drilling Protocols
Comparative Analysis of Patient Experience Among Under-drilling and Conventional Drilling in Dental Implants: a Randomized Double-blinded Study.
The goal of this clinical trial is to learn whether the drilling technique used to prepare the implant site affects the experience and satisfaction of adult patients receiving dental implants. The main questions it aims to answer are:
- Do patients treated with under-drilling report a different experience, satisfaction and postoperative discomfort than patients treated with conventional drilling?
- How are implant insertion torque, implant stability and bone density related to the pain and experience reported by patients?
Researchers will compare under-drilling (the implant site is prepared with a slightly narrower final drill than usual) with conventional drilling (the standard drilling sequence for the implant diameter). Both are standard clinical techniques.
Participants will:
- Be randomly assigned to one of the two techniques, without knowing which one they receive
- Have their dental implant(s) placed at the CEU Cardenal Herrera University Dental Clinic
- Complete a questionnaire about their experience before surgery and immediately after surgery
- Record their experience every day during the first week after surgery
- Complete a quality-of-life questionnaire (OHIP-14) one week after surgery
Descripción general del estudio
Estado
Condiciones
Intervención / Tratamiento
Descripción detallada
Study design: Single-center, randomized, double-blind, parallel-group clinical trial with two arms (1:1 allocation). Although the ethics committee-approved protocol describes the study as a randomized double-blinded cohort observational study, participants are randomly allocated to one of two standard implant site preparation techniques; the study is therefore registered as interventional according to ClinicalTrials.gov definitions. No experimental products are used.
Randomization and blinding: A computer-generated random sequence, stratified by age and sex, will be prepared before the start of the study and kept concealed. The surgeon will be informed of the allocated technique only at the time of surgery. Participants and the statistician performing the data analysis will remain blinded to group allocation.
Surgical procedure: All procedures will be performed under local anesthesia (4% articaine with 1:100,000 epinephrine) using a crestal mucoperiosteal incision and saline irrigation. In both groups, the osteotomy starts with a lanceolate drill and a 2 mm pilot drill to the planned length. In the under-drilling group, the drilling sequence stops at the drill prior to the standard final drill for the implant diameter; in the conventional group, the manufacturer's standard sequence is completed. Nobel Biocare or 3i implants will be used. Insertion torque will be recorded with the surgical motor and implant stability (ISQ) will be measured after placement. Bone density will be classified according to Misch (D1-D4) using preoperative 3D imaging and intraoperative assessment.
Perioperative care (identical in both groups): 0.12% chlorhexidine mouthwash before and after surgery, antibiotic prophylaxis and postoperative antibiotic treatment (amoxicillin, or azithromycin in penicillin-allergic patients), dexketoprofen as anti-inflammatory, and paracetamol 1 g as rescue analgesic.
Data collection: Sociodemographic and anthropometric data (age, sex, education level, employment status, weight, height and medication use) will be recorded. Patient experience will be assessed with an 11-item visual analogue scale (0-100 mm) before surgery, immediately after surgery and daily during the first 7 postoperative days. Oral health-related quality of life will be assessed with the OHIP-14 at day 7.
Sample size: Based on an estimated standard deviation of 1.5 and a minimum clinically important difference of 1.17, with alpha = 0.05 and 80% power, 26 participants per group are required (52 in total). Allowing for losses, 62 participants will be enrolled.
Statistical analysis: Independent t-tests, Pearson's chi-square and Fisher's exact tests will be used, with a significance level of 5%.
Tipo de estudio
Inscripción (Estimado)
Fase
- No aplica
Contactos y Ubicaciones
Estudio Contacto
- Nombre: RAQUEL GONZÁLEZ-MARTÍNEZ, DDS, MSc, PhD
- Número de teléfono: 0034961369000
- Correo electrónico: raquel.gonzalez@uchceu.es
Copia de seguridad de contactos de estudio
- Nombre: GABRIELE MARZORATI, DDS
- Correo electrónico: gabriele.marzorati1@uchceu.es
Ubicaciones de estudio
-
-
Valencia
-
Alfara del Patriarca, Valencia, España, 46115
- Clínica Odontológica Universitaria, Universidad CEU Cardenal Herrera
-
Contacto:
- CRISTINA AGUEDA TOME
- Número de teléfono: +34 961369000
- Correo electrónico: cristina.agueda@uchceu.es
-
-
Criterios de participación
Criterio de elegibilidad
Edades elegibles para estudiar
Acepta Voluntarios Saludables
Géneros elegibles para el estudio
Descripción
Inclusion Criteria:
- Age 18 years or older
- Partially or completely edentulous patients requiring dental implant placement
- Signed informed consent
Exclusion Criteria:
- Use of psychotropic or pain-modulating medication
- Systemic conditions affecting bone healing
- Use of medication known to interfere with bone metabolism
- Pregnancy or breastfeeding
- Allergy or intolerance to implant materials (e.g., titanium, zirconia)
- Severe bruxism or severe temporomandibular joint (TMJ) disorders
- Inability to follow postoperative care protocols or maintain basic oral hygiene
- Psychological or cognitive impairment that may interfere with understanding or following postoperative care instructions
- Inability to attend follow-up visits
- Previous implant failure
Plan de estudios
¿Cómo está diseñado el estudio?
Detalles de diseño
- Propósito principal: Tratamiento
- Asignación: Aleatorizado
- Modelo Intervencionista: Asignación paralela
- Enmascaramiento: Doble
Armas e Intervenciones
Grupo de participantes/brazo |
Intervención / Tratamiento |
|---|---|
|
Experimental: Under-drilling (UD)
Participants receive dental implant(s) placed using the under-drilling technique. |
Implant site preparation with a lanceolate drill and a 2 mm pilot drill to the planned length, followed by the manufacturer's drilling sequence stopping at the drill prior to the standard final drill for the implant diameter, with saline irrigation. Nobel Biocare or 3i implants are placed and insertion torque is recorded. |
|
Comparador activo: Conventional drilling (CO)
Participants receive dental implant(s) placed using the conventional drilling technique. |
Implant site preparation with a lanceolate drill and a 2 mm pilot drill to the planned length, followed by the manufacturer's complete standard drilling sequence for the implant diameter, with saline irrigation. Nobel Biocare or 3i implants are placed and insertion torque is recorded. |
¿Qué mide el estudio?
Medidas de resultado primarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Patient Experience and Satisfaction (Visual Analogue Scale)
Periodo de tiempo: Preoperatively (baseline), immediately after surgery, and daily on postoperative days 1 to 7
|
Patient experience with the treatment assessed with an 11-item visual analogue scale (VAS). Each item is scored on a 100 mm line (0 = low, 50 = moderate, 100 = extreme). Higher scores indicate greater intensity of the assessed experience. |
Preoperatively (baseline), immediately after surgery, and daily on postoperative days 1 to 7
|
Medidas de resultado secundarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Oral Health-Related Quality of Life (OHIP-14)
Periodo de tiempo: 7 days after surgery
|
Oral Health Impact Profile-14 questionnaire, covering 7 dimensions (functional limitation, physical pain, psychological discomfort, physical disability, psychological disability, social disability and handicap) with 2 items each. Total score range 0-56; higher scores indicate worse oral health-related quality of life. |
7 days after surgery
|
|
Implant Stability Quotient (ISQ)
Periodo de tiempo: During surgery (day 0)
|
Primary implant stability measured by resonance frequency analysis immediately after implant placement (ISQ units, 1-100; higher values indicate greater stability). |
During surgery (day 0)
|
|
Implant Survival
Periodo de tiempo: 7 days after surgery
|
Presence of the implant in situ without mobility, pain or signs of infection requiring removal. |
7 days after surgery
|
|
Implant Insertion Torque
Periodo de tiempo: During surgery (day 0)
|
Insertion torque (Ncm) recorded by the surgical motor (OsseoSet 300) at implant placement. |
During surgery (day 0)
|
Otras medidas de resultado
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Bone Density (Misch Classification)
Periodo de tiempo: Preoperatively and during surgery (day 0)
|
Bone density at the implant site classified as D1-D4 according to Misch, assessed on preoperative 3D imaging and confirmed intraoperatively during drilling. |
Preoperatively and during surgery (day 0)
|
Colaboradores e Investigadores
Patrocinador
Investigadores
- Investigador principal: RAQUEL GONZÁLEZ-MARTÍNEZ, DDS, MSc, PhD, Cardenal Herrera University
- Investigador principal: ISIDORO CORTELL-BALLESTER, MD, DDS, MSc, PhD, Cardenal Herrera University
Fechas de registro del estudio
Fechas importantes del estudio
Inicio del estudio (Estimado)
Finalización primaria (Estimado)
Finalización del estudio (Estimado)
Fechas de registro del estudio
Enviado por primera vez
Primero enviado que cumplió con los criterios de control de calidad
Publicado por primera vez (Actual)
Actualizaciones de registros de estudio
Última actualización publicada (Actual)
Última actualización enviada que cumplió con los criterios de control de calidad
Última verificación
Más información
Términos relacionados con este estudio
Palabras clave
Términos MeSH relevantes adicionales
- Dolor
- Manifestaciones neurológicas
- Enfermedades musculoesqueléticas
- Enfermedades de la Boca
- Enfermedades Estomatognáticas
- Complicaciones Postoperatorias
- Procesos Patológicos
- Enfermedades de la mandíbula
- Enfermedades de los dientes
- Boca desdentada
- Condiciones Patológicas, Signos y Síntomas
- Comportamiento
- Signos y síntomas
- Adherencia y Cumplimiento del Tratamiento
- Comportamiento de salud
- Dolor Postoperatorio
- Mandíbula Desdentada
- Satisfacción del paciente
Otros números de identificación del estudio
- CEEI25_699
Plan de datos de participantes individuales (IPD)
¿Planea compartir datos de participantes individuales (IPD)?
Descripción del plan IPD
Individual participant data will not be shared. In accordance with the protocol approved by the ethics committee and with the EU General Data Protection Regulation (GDPR) and Spanish Organic Law 3/2018, access to the data is restricted to the research team, and the data will be destroyed after publication of the results.
Información sobre medicamentos y dispositivos, documentos del estudio
Estudia un producto farmacéutico regulado por la FDA de EE. UU.
Estudia un producto de dispositivo regulado por la FDA de EE. UU.
Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .